Last reviewed · How we verify
NCT07337083
Prediabetes in End Stage Renal Disease on Dialysis
trial in Screening in 262 participants. Completed in 12 October 2025.
13 September 2025
Quick facts
| Lead sponsor | Sohag University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 262 |
| Start date | 13 April 2025 |
| Primary completion | 13 September 2025 |
| Estimated completion | 12 October 2025 |
| Sites | 2 locations across Egypt |
Conditions studied
- Screening — all drugs for Screening →
- Pre Diabetic — all drugs for Pre Diabetic →
- Chronic Renal Failure (CRF) — all drugs for Chronic Renal Failure (CRF) →
- Dialysis Patients — all drugs for Dialysis Patients →
Sponsor
Sohag University
Who can join
18 and older, any sex, with Screening or Pre Diabetic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prediabetes is a highly prevalent condition, affecting about one-third of adults in the United States Patients with prediabetes have an increased risk for diabetes, with 2% to 10% progressing to diabetes each yea Although prediabetes is frequently considered an intermediary stage in the progression between normoglycemia and diabetes, many individuals may have prediabetes for several years, while some may never progress.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07337083
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Screening
Currently open trials in the same condition.
- NCT07277686 — AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population · recruiting
- NCT07125365 — UK Islet Autoantibody Registry · recruiting
- NCT06792188 — Smartwatch-Based AI Model for OSA Prediction (SWOSA) · recruiting
- NCT06870435 — Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcin · NA · recruiting
- NCT06799793 — Artificial Intelligence-based Screening Models for Prevention and Early Detection of Colorectal Cancer · NA · recruiting
Other Sohag University trials
Trials by the same sponsor.
- NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
- NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
- NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
- NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07337083 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sohag University
- Last refreshed: 13 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07337083.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing